Chimæra analysis of profiles of PC1 suggested two predominant tumor subclones that are represented in Fig. 7b by predicted deleterious mutations in EP300 (p.I997V) and AR (p.T878A); Fig. 7b. This evidence concerns the gene AR and neoplasm.